DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Remodulin (Treprostinil Subcutaneous) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Remodulin (Treprostinil Subcutaneous) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Remodulin side effects in 44 year old female

Reported by a physician from United States on 2012-04-30

Patient: 44 year old female, weighing 58.2 kg (128.0 pounds)

Reactions: Right Ventricular Failure, Dehydration, Sepsis, Blood Pressure Decreased, White Blood Cell Count Increased, Infusion Site Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Remodulin

Other drugs received by patient: Revatio; Diuretics (Diuretics)



Possible Remodulin side effects in 76 year old male

Reported by a physician from United States on 2012-03-22

Patient: 76 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Respiratory Failure

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Tyvaso
    Dosage: 72 mcg (18 mcg, 4 in 1 d) , inhalation
    Indication: Pulmonary Arterial Hypertension
    Start date: 2012-02-07

Remodulin
    Dosage: 31.68 ug/kg (0.022 ug/kg, 1 in 1 min) , subcutaneous
    Indication: Pulmonary Arterial Hypertension
    Start date: 2011-01-17

Other drugs received by patient: Adcirca; Letairis

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017